Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorBILLAMBOZ, Muriel
dc.contributor.authorSUCHAUD, Virginie
dc.contributor.authorBAILLY, Fabrice
dc.contributor.authorLION, Cedric
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorANDREOLA, Marie-Line
dc.contributor.authorCHRIST, Frauke
dc.contributor.authorDEBYSER, Zeger
dc.contributor.authorCOTELLE, Philippe
dc.date.accessioned2023-07-04T13:01:28Z
dc.date.available2023-07-04T13:01:28Z
dc.date.issued2016-07-19
dc.identifier.issn0223-5234en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/183273
dc.description.abstractEnHerein, we report further insight into the biological activities displayed by the 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) scaffold. Previous studies have evidenced the marked fruitful effect of substitution of this two-metal binding pharmacophore at position 4 by phenyl and benzyl carboxamido chains. Strong human immunodeficiency virus type 1 integrase (HIV-1 IN) inhibitors in the low nanomolar range with micromolar (even down to low nanomolar) anti-HIV activities were obtained. Keeping this essential 4-carboxamido function, we investigated the influence of the replacement of phenyl and benzyl groups by various alkyl chains. This study shows that the recurrent halogenobenzyl pharmacophore found in the INSTIs can be efficiently replaced by an n-alkyl group. With an optimal length of six carbons, we observed a biological profile and a high barrier to resistance equivalent to those of a previously reported hit compound bearing a 4-fluorobenzyl group.
dc.language.isoENen_US
dc.subject.enTwo-metal binding pharmacophore
dc.subject.en2-hydroxyisoquinoline-1
dc.subject.en3(2H
dc.subject.en4H)-diones
dc.subject.enAntiretroviral
dc.subject.enHIV-1 integrase
dc.title2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.ejmech.2016.03.083en_US
dc.subject.halSciences du Vivant [q-bio]en_US
bordeaux.page256-268en_US
bordeaux.volume117en_US
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcehal
hal.identifierhal-03174247
hal.version1
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
workflow.import.sourcehal
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.title=2-hydroxyisoquinoline-1,3(2H,4H)-diones%20(HIDs)%20as%20human%20immunodeficiency%20virus%20type%201%20integrase%20inhibitors:%20Influence%20of%20the%20alkylcarboxamide%20&rft.atitle=2-hydroxyisoquinoline-1,3(2H,4H)-diones%20(HIDs)%20as%20human%20immunodeficiency%20virus%20type%201%20integrase%20inhibitors:%20Influence%20of%20the%20alkylcarboxamide%2&rft.date=2016-07-19&rft.volume=117&rft.spage=256-268&rft.epage=256-268&rft.eissn=0223-5234&rft.issn=0223-5234&rft.au=BILLAMBOZ,%20Muriel&SUCHAUD,%20Virginie&BAILLY,%20Fabrice&LION,%20Cedric&ANDREOLA,%20Marie-Line&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée